Moderna Inc (MRNA)
117.32
-5.37
(-4.38%)
USD |
NASDAQ |
May 10, 16:00
117.02
-0.30
(-0.26%)
After-Hours: 19:18
Moderna Cash from Operations (TTM): -2.882B for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -2.882B |
December 31, 2023 | -3.118B |
September 30, 2023 | -2.078B |
June 30, 2023 | -226.00M |
March 31, 2023 | 993.00M |
December 31, 2022 | 4.981B |
September 30, 2022 | 6.629B |
June 30, 2022 | 9.653B |
March 31, 2022 | 13.41B |
December 31, 2021 | 13.62B |
September 30, 2021 | 11.57B |
Date | Value |
---|---|
June 30, 2021 | 9.191B |
March 31, 2021 | 5.104B |
December 31, 2020 | 2.027B |
September 30, 2020 | 663.95M |
June 30, 2020 | -336.15M |
March 31, 2020 | -420.73M |
December 31, 2019 | -459.00M |
September 30, 2019 | -450.97M |
June 30, 2019 | -424.08M |
March 31, 2019 | -363.75M |
December 31, 2018 | -330.86M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-3.118B
Minimum
Dec 2023
13.62B
Maximum
Dec 2021
3.373B
Average
828.47M
Median
Cash from Operations (TTM) Benchmarks
Merck & Co Inc | 14.76B |
Pfizer Inc | 8.578B |
Eli Lilly and Co | 3.676B |
Johnson & Johnson | 23.19B |
Novavax Inc | -713.97M |